Cargando…
Milestones toward cochlear gene therapy for patients with hereditary hearing loss
A number of genes are reportedly responsible for hereditary hearing loss, which accounts for over 50% of all congenital hearing loss cases. Recent advances in genetic testing have enabled the identification of pathogenic variants in many cases, and systems have been developed to provide personalized...
Autores principales: | Yoshimura, Hidekane, Nishio, Shin‐Ya, Usami, Shin‐Ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513455/ https://www.ncbi.nlm.nih.gov/pubmed/34693000 http://dx.doi.org/10.1002/lio2.633 |
Ejemplares similares
-
Threshold sound conditioning in the treatment of sensorineural hearing loss
por: Kwak, Eunyee, et al.
Publicado: (2020) -
Providing health care to patients with hearing loss during COVID‐19 and physical distancing
por: West, Jessica S., et al.
Publicado: (2020) -
Clinical manifestations of hereditary angioedema and a systematic review of treatment options
por: Rosi‐Schumacher, Mattie, et al.
Publicado: (2021) -
Cochlear Implantation From the Perspective of Genetic Background
por: Usami, Shin‐ichi, et al.
Publicado: (2020) -
Prevalence and significance of cranial nerve imaging abnormalities in patients with hereditary neuropathies: Clinical implications at the skull base
por: Bartholomew, Ryan A., et al.
Publicado: (2020)